Given its known role in neuroinflammatory and neurodegenerative disorders (Nazarinia et al., 2022) and cancer, (Zajkowska and Mroczko, 2021), elevated CCL11 in SCD could indicate neurologic complications during hemolysis-related crises. This evidence concerns the gene CCL11 and cancer.